Literature DB >> 27891635

Potential Association between Drug Shortages and High-Cost Medications.

Erin R Fox1, Linda S Tyler1.   

Abstract

Shortages and sudden price increases of certain drugs may both occur emergently, with little to no warning, and they can have a dramatic impact on patient care. Little data are available linking drug shortages and price increases. Many of the same characteristics that may make medications susceptible to shortages can also place them at risk for sudden price increases. These characteristics include unapproved drugs, off-patent sole-source medications, and infrequently used medications. We reviewed drug shortage data from the University of Utah Drug Information Service to demonstrate how frequently these characteristics occurred and resulted in higher drug prices. Clinicians can use drug shortage management principles to mitigate the impact of sudden price increases for patients and health care organizations.
© 2016 Pharmacotherapy Publications, Inc.

Entities:  

Keywords:  drug information; drug shortage; high cost

Mesh:

Substances:

Year:  2016        PMID: 27891635     DOI: 10.1002/phar.1861

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  5 in total

1.  Medicine shortages: Product life cycle phases and characteristics of medicines in short supply-A register study.

Authors:  Kati Sarnola; Heini Kari; Hanna Koskinen
Journal:  Front Pharmacol       Date:  2022-06-27       Impact factor: 5.988

2.  Systemic Measures and Legislative and Organizational Frameworks Aimed at Preventing or Mitigating Drug Shortages in 28 European and Western Asian Countries.

Authors:  Tomasz Bochenek; Vafa Abilova; Ali Alkan; Bogdan Asanin; Iñigo de Miguel Beriain; Zeljka Besovic; Patricia Vella Bonanno; Anna Bucsics; Michal Davidescu; Elfi De Weerdt; Natasa Duborija-Kovacevic; Jurij Fürst; Mina Gaga; Elma Gailīte; Jolanta Gulbinovič; Emre U Gürpınar; Balázs Hankó; Vincent Hargaden; Tor A Hotvedt; Iris Hoxha; Isabelle Huys; Andras Inotai; Arianit Jakupi; Helena Jenzer; Roberta Joppi; Ott Laius; Marie-Camille Lenormand; Despina Makridaki; Admir Malaj; Kertu Margus; Vanda Marković-Peković; Nenad Miljković; João L de Miranda; Stanislav Primožič; Dragana Rajinac; David G Schwartz; Robin Šebesta; Steven Simoens; Juraj Slaby; Ljiljana Sović-Brkičić; Tomas Tesar; Leonidas Tzimis; Ewa Warmińska; Brian Godman
Journal:  Front Pharmacol       Date:  2018-01-18       Impact factor: 5.810

3.  Outcomes of a drug shortage requiring switching in patients with ulcerative colitis.

Authors:  Daniel R van Langenberg; Richard Kai-Yuan Cheng; Mayur Garg
Journal:  World J Gastrointest Pathophysiol       Date:  2020-04-12

4.  The French reporting system for drug shortages: description and trends from 2012 to 2018: an observational retrospective study.

Authors:  Amine Benhabib; Saïd Ioughlissen; Christelle Ratignier-Carbonneil; Patrick Maison
Journal:  BMJ Open       Date:  2020-03-04       Impact factor: 2.692

Review 5.  Drug Shortage: Causes, Impact, and Mitigation Strategies.

Authors:  Sundus Shukar; Fatima Zahoor; Khezar Hayat; Amna Saeed; Ali Hassan Gillani; Sumaira Omer; Shuchen Hu; Zaheer-Ud-Din Babar; Yu Fang; Caijun Yang
Journal:  Front Pharmacol       Date:  2021-07-09       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.